COMPANY WIRE
01 OCT 2025 / Significo announces Series B at $100M valuationBalm + Recco / Product development, global expansion, planned acquisitions

Company / Digital health / Significo

Significo and the health app nobody opens

The hard part of digital health is getting people to come back. Significo builds the recommendations, software and treatment pathways that give them a reason to.

There is a revealing number in one of Significo’s insurance case studies: 3.5%. Fewer than that proportion of an insurer’s members had enrolled in its health platform. Among those who did, only 7% used it beyond twelve weeks. Somewhere between the promise of better health and the thirteenth week, almost everybody had found something else to do.

This is an awkward starting point for a technology business. The software exists. The organization has members. The subject could hardly matter more. Yet attendance is dismal. Significo’s proposition begins with that gap: build health software around the person expected to use it, then make the next useful action easier to find.

The useful bits / 30 seconds
  • Recco personalizes health recommendations inside another company’s digital experience.
  • Balm offers guided health programs, with consumer and organizational access.
  • Custom development serves insurers, employers and health businesses that need their own software.

The 3.5% problem

For the unnamed insurer, Significo supplied Recco, its recommendation engine, within a broader wellbeing platform. The experience combined assessments, activity, mindfulness, meal planning and connected devices. Recommendations drew on user information and preferences; reminders and points supplied nudges to return.

Significo reports that personalized recommendations kept people active in host platforms for an average of 2.5 times longer than the previous baseline. Its insurer case study also reports 19.9% monthly enrollment growth and 32% sustained, meaningful engagement after Recco was incorporated into a similar platform. These are company-reported measures with different definitions. They describe encouraging participation; they do not establish that personalization alone caused better health.

Recco / company-reported project result
2.5×

Longer average activity in the host platform than the previous baseline.

Relative activity, not a clinical outcome. Reported across Significo projects.

Sell the engine, build the experience

Recco can arrive as a software development kit, an API or a custom application. For a buyer, the appeal is practical: add personalization without assembling the entire specialist team internally. Significo also builds bespoke mobile apps, web platforms and dashboards, and handles data integration, hosting and maintenance.

That makes it both a software supplier and a development partner. Its buyers include insurers, benefits providers, employers and other healthcare businesses. Named testimonials come from HealthCheck360 and Vitaservices. The commercial model combines custom engagements with licensing and customization of proprietary products. A buyer can commission an experience or incorporate an existing component.

The distinction matters in a crowded market. A corporate wellness platform sells a ready-made destination; an internal engineering team builds one. Significo offers parts as well as the finished room. Its claimed advantage is the combination of behavioral expertise, health knowledge, design and engineering. That combination still has to earn its keep on each contract.

A diary, a recipe, a reason to return

Consider its smoking-cessation app for an insurance provider. Users record cravings, identify triggers and collect reasons for quitting. They can see cigarettes not smoked and money saved. Coaching includes preparation checklists and help after relapse. The product makes a difficult, uneven process legible, including the moments when resolve goes missing.

Another insurer app combines exercise, nutrition and relaxation. It includes approximately 500 recipes, a nutrient calculator, Pilates, Hatha yoga and progress feedback, alongside the insurer’s bonus program. Significo reports threefold customer engagement growth after launch. The telling detail is the range of ordinary decisions covered: what to cook, how to move, when to pause.

In occupational health, questionnaires inform a Health Index and recommendations across mental health, workplace health and behavior. Significo describes that app as a pocket guide rather than something designed to keep users hooked. For a health product, the useful activity may happen after the screen goes dark.

Balm and the price of getting in

Balm provides the guided-program side of the business. Its consumer site describes paths for anxiety, depression, chronic pain, sleep and type 2 diabetes prevention. Programs use cognitive and behavioral techniques, with recommended durations of six to twelve weeks. An individual can try seven days free, then pay $9.99 a month on an automatically renewing subscription.

Balm mobile dashboard showing anxiety program progress and a type 2 diabetes prevention path
Balm / inside the productA place to
pick up again.

Program progress, a next action and a daily routine in one view.

01 / Continue
The quiet art of coming back. Balm’s published interface puts unfinished work within reach. Product image: Significo.

The German insurer offer follows different economics. Its page lists four CE-certified Class I medical-device programs at €99 each through selective contracts. That price and the consumer subscription describe different offers. Balm also supports organizational integration and bringing third-party offerings into one platform.

The ambition is easier access between appointments. Self-guided programs depend on a person being able to use them; Balm explicitly directs people in crisis elsewhere. Its device classification is a regulatory description. It should never be mistaken for a guarantee of an individual result.

Buying the missing pieces

Significo dates its founding to 2014. Its history identifies cumbersome employee wellbeing products as an early frustration: employers required features that individuals did not particularly want. The company expanded through custom work and acquisitions, bringing in Vilua Healthcare in 2022, followed by Piobyte and Bunch in 2024.

Piobyte contributed software and healthcare-compliance expertise from Potsdam. Bunch contributed AI leadership coaching and a team spanning psychology, data science, engineering and design. The connection is workplace stress: a manager’s behavior can shape the health of the people around them. Acquiring that expertise broadens what Significo can build.

Rick McCartney, Significo co-founder and CEO
The person questioning the prescription queue. Co-founder and CEO Rick McCartney argues for simpler access to digital health programs. Portrait: Significo.

A $12 million Series A in June 2023 was led by Doug Blough. In October 2025, Significo announced a Series B led by JSTAR Capital Investments’ Horizon Fund II, at a $100 million valuation. Its stated plans included complementary acquisitions, international expansion and development of Balm and Recco. The financing announcement makes connection and consolidation explicit business priorities.

Copy the route, then count the return

In a June 2025 essay, CEO Rick McCartney called software “a research-delivery platform.” He advocated immediate patient access and payment linked to results. That is a proposal about how digital care should work, rather than evidence that every Significo contract already works that way.

“Software is a research-delivery platform.”

Rick McCartney / June 2025

The lesson a product team can copy is smaller and concrete. Put help inside an existing experience. Make progress visible. Allow for lapses. Measure whether people return and complete useful work. Those choices need reliable inputs, workable integration and appropriate care pathways. Otherwise, another personalized feed may simply become another place to stop visiting.